How Big Will the SpaceX IPO Be?
Operated up to now as a private business, SpaceX will…
Sell
28
GTBIF Quote, Financials, Valuation and Earnings
Last price:
$6.90
Seasonality move
:
8.03%
Day range:
$6.71 - $7.25
52-week range:
$4.63 - $10.43
Dividend yield:
0%
P/E ratio:
37.28x
P/S ratio:
1.41x
P/B ratio:
0.87x
Volume:
666.2K
Avg. volume:
685.9K
1-year change:
-0.29%
Market cap:
$1.6B
Revenue:
$1.1B
EPS (TTM):
$0.19
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
GTBIF
Green Thumb Industries, Inc.
|
$296.1M | -$0.01 | 0.59% | -100% | $13.63 |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$3M | -$0.88 | 14.03% | -95.43% | $0.85 |
|
OGEN
Oragenics, Inc.
|
-- | -- | -- | -- | $2.00 |
|
PTN
Palatin Technologies
|
-- | -$0.17 | -- | -67.93% | -- |
|
TLRY
Tilray Brands, Inc.
|
$211.1M | -- | 8.82% | -100% | $11.83 |
|
TOVX
Theriva Biologics, Inc.
|
-- | -$0.37 | -- | -94.42% | $7.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
GTBIF
Green Thumb Industries, Inc.
|
$6.90 | $13.63 | $1.6B | 37.28x | $0.00 | 0% | 1.41x |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$1.85 | $0.85 | $233.4M | 3.11x | $0.80 | 0% | 3.59x |
|
OGEN
Oragenics, Inc.
|
$0.82 | $2.00 | $675.8K | -- | $0.00 | 0% | 0.53x |
|
PTN
Palatin Technologies
|
$0.09 | -- | $2.4M | -- | $0.00 | 0% | -- |
|
TLRY
Tilray Brands, Inc.
|
$7.62 | $11.83 | $883.9M | -- | $0.00 | 0% | 0.92x |
|
TOVX
Theriva Biologics, Inc.
|
$0.19 | $7.00 | $6.3M | -- | $0.00 | 0% | 0.33x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
GTBIF
Green Thumb Industries, Inc.
|
22.08% | -0.320 | 27.88% | 1.19x |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
37.25% | -3.190 | 8.08% | 1.85x |
|
OGEN
Oragenics, Inc.
|
3.86% | 0.905 | 36.62% | 3.97x |
|
PTN
Palatin Technologies
|
-- | 1.358 | -- | -- |
|
TLRY
Tilray Brands, Inc.
|
16.83% | 2.675 | 35.13% | 1.54x |
|
TOVX
Theriva Biologics, Inc.
|
29.07% | -2.522 | 66.16% | 0.68x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
GTBIF
Green Thumb Industries, Inc.
|
$137.5M | $36.7M | 1.97% | 2.54% | 12.61% | $57.2M |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$42K | -$1.2M | -208.55% | -306.03% | -224.38% | -$1.8M |
|
OGEN
Oragenics, Inc.
|
-- | -$3.1M | -311.49% | -509.23% | -- | -$3M |
|
PTN
Palatin Technologies
|
-- | -- | -- | -- | -- | -- |
|
TLRY
Tilray Brands, Inc.
|
$53.1M | -$20M | -84.8% | -98.18% | -9.2% | -$18M |
|
TOVX
Theriva Biologics, Inc.
|
-$28K | -$4.4M | -148.18% | -171.04% | -- | -$4.3M |
Green Thumb Industries, Inc. vs. Competitors
-
Which has Higher Returns GTBIF or NBY?
NovaBay Pharmaceuticals, Inc. has a net margin of 8.17% compared to Green Thumb Industries, Inc.'s net margin of -255.85%. Green Thumb Industries, Inc.'s return on equity of 2.54% beat NovaBay Pharmaceuticals, Inc.'s return on equity of -306.03%.
Company Gross Margin Earnings Per Share Invested Capital GTBIFGreen Thumb Industries, Inc.47.18% $0.10 $2.4B NBYNovaBay Pharmaceuticals, Inc.8.06% -$0.22 $2.6M -
What do Analysts Say About GTBIF or NBY?
Green Thumb Industries, Inc. has a consensus price target of $13.63, signalling upside risk potential of 97.47%. On the other hand NovaBay Pharmaceuticals, Inc. has an analysts' consensus of $0.85 which suggests that it could fall by -54.05%. Given that Green Thumb Industries, Inc. has higher upside potential than NovaBay Pharmaceuticals, Inc., analysts believe Green Thumb Industries, Inc. is more attractive than NovaBay Pharmaceuticals, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GTBIFGreen Thumb Industries, Inc.8 0 0 NBYNovaBay Pharmaceuticals, Inc.1 0 0 -
Is GTBIF or NBY More Risky?
Green Thumb Industries, Inc. has a beta of 0.939, which suggesting that the stock is 6.062% less volatile than S&P 500. In comparison NovaBay Pharmaceuticals, Inc. has a beta of 0.093, suggesting its less volatile than the S&P 500 by 90.725%.
-
Which is a Better Dividend Stock GTBIF or NBY?
Green Thumb Industries, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NovaBay Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.80 per share. Green Thumb Industries, Inc. pays -- of its earnings as a dividend. NovaBay Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GTBIF or NBY?
Green Thumb Industries, Inc. quarterly revenues are $291.4M, which are larger than NovaBay Pharmaceuticals, Inc. quarterly revenues of $521K. Green Thumb Industries, Inc.'s net income of $23.8M is higher than NovaBay Pharmaceuticals, Inc.'s net income of -$1.3M. Notably, Green Thumb Industries, Inc.'s price-to-earnings ratio is 37.28x while NovaBay Pharmaceuticals, Inc.'s PE ratio is 3.11x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Green Thumb Industries, Inc. is 1.41x versus 3.59x for NovaBay Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GTBIFGreen Thumb Industries, Inc.1.41x 37.28x $291.4M $23.8M NBYNovaBay Pharmaceuticals, Inc.3.59x 3.11x $521K -$1.3M
-
Which has Higher Returns GTBIF or OGEN?
Oragenics, Inc. has a net margin of 8.17% compared to Green Thumb Industries, Inc.'s net margin of --. Green Thumb Industries, Inc.'s return on equity of 2.54% beat Oragenics, Inc.'s return on equity of -509.23%.
Company Gross Margin Earnings Per Share Invested Capital GTBIFGreen Thumb Industries, Inc.47.18% $0.10 $2.4B OGENOragenics, Inc.-- -$1.96 $10.2M -
What do Analysts Say About GTBIF or OGEN?
Green Thumb Industries, Inc. has a consensus price target of $13.63, signalling upside risk potential of 97.47%. On the other hand Oragenics, Inc. has an analysts' consensus of $2.00 which suggests that it could grow by 143.55%. Given that Oragenics, Inc. has higher upside potential than Green Thumb Industries, Inc., analysts believe Oragenics, Inc. is more attractive than Green Thumb Industries, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GTBIFGreen Thumb Industries, Inc.8 0 0 OGENOragenics, Inc.1 0 0 -
Is GTBIF or OGEN More Risky?
Green Thumb Industries, Inc. has a beta of 0.939, which suggesting that the stock is 6.062% less volatile than S&P 500. In comparison Oragenics, Inc. has a beta of 0.903, suggesting its less volatile than the S&P 500 by 9.685%.
-
Which is a Better Dividend Stock GTBIF or OGEN?
Green Thumb Industries, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Oragenics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Green Thumb Industries, Inc. pays -- of its earnings as a dividend. Oragenics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GTBIF or OGEN?
Green Thumb Industries, Inc. quarterly revenues are $291.4M, which are larger than Oragenics, Inc. quarterly revenues of --. Green Thumb Industries, Inc.'s net income of $23.8M is higher than Oragenics, Inc.'s net income of -$3.1M. Notably, Green Thumb Industries, Inc.'s price-to-earnings ratio is 37.28x while Oragenics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Green Thumb Industries, Inc. is 1.41x versus 0.53x for Oragenics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GTBIFGreen Thumb Industries, Inc.1.41x 37.28x $291.4M $23.8M OGENOragenics, Inc.0.53x -- -- -$3.1M
-
Which has Higher Returns GTBIF or PTN?
Palatin Technologies has a net margin of 8.17% compared to Green Thumb Industries, Inc.'s net margin of --. Green Thumb Industries, Inc.'s return on equity of 2.54% beat Palatin Technologies's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GTBIFGreen Thumb Industries, Inc.47.18% $0.10 $2.4B PTNPalatin Technologies-- -- -- -
What do Analysts Say About GTBIF or PTN?
Green Thumb Industries, Inc. has a consensus price target of $13.63, signalling upside risk potential of 97.47%. On the other hand Palatin Technologies has an analysts' consensus of -- which suggests that it could grow by 7338.9%. Given that Palatin Technologies has higher upside potential than Green Thumb Industries, Inc., analysts believe Palatin Technologies is more attractive than Green Thumb Industries, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GTBIFGreen Thumb Industries, Inc.8 0 0 PTNPalatin Technologies0 0 0 -
Is GTBIF or PTN More Risky?
Green Thumb Industries, Inc. has a beta of 0.939, which suggesting that the stock is 6.062% less volatile than S&P 500. In comparison Palatin Technologies has a beta of 0.939, suggesting its less volatile than the S&P 500 by 6.103%.
-
Which is a Better Dividend Stock GTBIF or PTN?
Green Thumb Industries, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Palatin Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Green Thumb Industries, Inc. pays -- of its earnings as a dividend. Palatin Technologies pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GTBIF or PTN?
Green Thumb Industries, Inc. quarterly revenues are $291.4M, which are larger than Palatin Technologies quarterly revenues of --. Green Thumb Industries, Inc.'s net income of $23.8M is higher than Palatin Technologies's net income of --. Notably, Green Thumb Industries, Inc.'s price-to-earnings ratio is 37.28x while Palatin Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Green Thumb Industries, Inc. is 1.41x versus -- for Palatin Technologies. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GTBIFGreen Thumb Industries, Inc.1.41x 37.28x $291.4M $23.8M PTNPalatin Technologies-- -- -- --
-
Which has Higher Returns GTBIF or TLRY?
Tilray Brands, Inc. has a net margin of 8.17% compared to Green Thumb Industries, Inc.'s net margin of -20%. Green Thumb Industries, Inc.'s return on equity of 2.54% beat Tilray Brands, Inc.'s return on equity of -98.18%.
Company Gross Margin Earnings Per Share Invested Capital GTBIFGreen Thumb Industries, Inc.47.18% $0.10 $2.4B TLRYTilray Brands, Inc.24.43% -$0.41 $1.9B -
What do Analysts Say About GTBIF or TLRY?
Green Thumb Industries, Inc. has a consensus price target of $13.63, signalling upside risk potential of 97.47%. On the other hand Tilray Brands, Inc. has an analysts' consensus of $11.83 which suggests that it could grow by 55.18%. Given that Green Thumb Industries, Inc. has higher upside potential than Tilray Brands, Inc., analysts believe Green Thumb Industries, Inc. is more attractive than Tilray Brands, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GTBIFGreen Thumb Industries, Inc.8 0 0 TLRYTilray Brands, Inc.2 7 0 -
Is GTBIF or TLRY More Risky?
Green Thumb Industries, Inc. has a beta of 0.939, which suggesting that the stock is 6.062% less volatile than S&P 500. In comparison Tilray Brands, Inc. has a beta of 1.775, suggesting its more volatile than the S&P 500 by 77.493%.
-
Which is a Better Dividend Stock GTBIF or TLRY?
Green Thumb Industries, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tilray Brands, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Green Thumb Industries, Inc. pays -- of its earnings as a dividend. Tilray Brands, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GTBIF or TLRY?
Green Thumb Industries, Inc. quarterly revenues are $291.4M, which are larger than Tilray Brands, Inc. quarterly revenues of $217.5M. Green Thumb Industries, Inc.'s net income of $23.8M is higher than Tilray Brands, Inc.'s net income of -$43.5M. Notably, Green Thumb Industries, Inc.'s price-to-earnings ratio is 37.28x while Tilray Brands, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Green Thumb Industries, Inc. is 1.41x versus 0.92x for Tilray Brands, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GTBIFGreen Thumb Industries, Inc.1.41x 37.28x $291.4M $23.8M TLRYTilray Brands, Inc.0.92x -- $217.5M -$43.5M
-
Which has Higher Returns GTBIF or TOVX?
Theriva Biologics, Inc. has a net margin of 8.17% compared to Green Thumb Industries, Inc.'s net margin of --. Green Thumb Industries, Inc.'s return on equity of 2.54% beat Theriva Biologics, Inc.'s return on equity of -171.04%.
Company Gross Margin Earnings Per Share Invested Capital GTBIFGreen Thumb Industries, Inc.47.18% $0.10 $2.4B TOVXTheriva Biologics, Inc.-- -$0.45 $9.5M -
What do Analysts Say About GTBIF or TOVX?
Green Thumb Industries, Inc. has a consensus price target of $13.63, signalling upside risk potential of 97.47%. On the other hand Theriva Biologics, Inc. has an analysts' consensus of $7.00 which suggests that it could grow by 3653.35%. Given that Theriva Biologics, Inc. has higher upside potential than Green Thumb Industries, Inc., analysts believe Theriva Biologics, Inc. is more attractive than Green Thumb Industries, Inc..
Company Buy Ratings Hold Ratings Sell Ratings GTBIFGreen Thumb Industries, Inc.8 0 0 TOVXTheriva Biologics, Inc.1 1 0 -
Is GTBIF or TOVX More Risky?
Green Thumb Industries, Inc. has a beta of 0.939, which suggesting that the stock is 6.062% less volatile than S&P 500. In comparison Theriva Biologics, Inc. has a beta of 0.343, suggesting its less volatile than the S&P 500 by 65.729%.
-
Which is a Better Dividend Stock GTBIF or TOVX?
Green Thumb Industries, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Theriva Biologics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Green Thumb Industries, Inc. pays -- of its earnings as a dividend. Theriva Biologics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GTBIF or TOVX?
Green Thumb Industries, Inc. quarterly revenues are $291.4M, which are larger than Theriva Biologics, Inc. quarterly revenues of --. Green Thumb Industries, Inc.'s net income of $23.8M is higher than Theriva Biologics, Inc.'s net income of -$4.4M. Notably, Green Thumb Industries, Inc.'s price-to-earnings ratio is 37.28x while Theriva Biologics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Green Thumb Industries, Inc. is 1.41x versus 0.33x for Theriva Biologics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GTBIFGreen Thumb Industries, Inc.1.41x 37.28x $291.4M $23.8M TOVXTheriva Biologics, Inc.0.33x -- -- -$4.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.7T
P/E Ratio: 66x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 42x
Alerts
Buy
82
STX alert for Jan 30
Seagate Technology Holdings Plc [STX] is up 0.83% over the past day.
Buy
80
LUV alert for Jan 30
Southwest Airlines Co. [LUV] is up 18.53% over the past day.
Buy
75
BNAI alert for Jan 30
Brand Engagement Network, Inc. [BNAI] is down 16.89% over the past day.
